Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs.
about
A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatmentThe interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity.Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.13-week subchronic toxicity study of a novel ginsenoside composition from ginseng leaves in rats.Isolation and analysis of ginseng: advances and challenges.Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy.Experimental application of Lactobacillus fermentum CCM 7421 in combination with chlorophyllin in dogs.Development and validation of an UPLC-Q/TOF-MS assay for the quantitation of neopanaxadiol in beagle dog plasma: Application to a pharmacokinetic study.Ginsenoside Rh2 enhances the antitumor immunological response of a melanoma mice model.Pharmacokinetics of panaxatrol disuccinate sodium, a novel anti-cancer drug from Panax notoginseng, in healthy volunteers and patients with advanced solid tumors.Metabolism of ginseng and its interactions with drugsGinsenoside Rh1 induces mouse osteoblast growth and differentiation through the bone morphogenetic protein 2/runt-related gene 2 signalling pathway.Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells.Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ-STAT3 Signaling in Type 1-Like Diabetic Rats.Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters.Ginsenoside Rh2 inhibits human A172 glioma cell proliferation and induces cell cycle arrest status via modulating Akt signaling pathway.Study on the interaction between ginsenoside Rh2 and calf thymus DNA by spectroscopic techniques.Pharmacokinetics and tissue distribution of ginsenoside Rh2 and Rg3 epimers after oral administration of BST204, a purified ginseng dry extract, in rats.Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2.Sulfated derivative of 20(S)-ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-induced RAW264.7 macrophages.Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability.
P2860
Q28483412-8DE6B761-6BBB-403B-AB50-2F4640836721Q33850000-BB2F5DBF-E153-4598-B620-C146909650D3Q34243995-F509B29F-06A2-42B9-9B45-9A9462BB7363Q34302714-C6159401-D23E-4DBA-96C9-EFE33BDD0427Q34667126-E4FC6010-F8DA-478A-856B-03CC90136B15Q35203734-C394571F-D9F3-44B2-B40D-4B086B9DE0B2Q35660356-30AC4061-2454-47F6-84CC-34CD9CDB4768Q36176846-B616D69C-C921-4D51-80E2-579C08981EB9Q37701177-A943E736-F368-45FE-AE05-C3D347BB7AD0Q37729869-220D9232-5FD9-422B-8EBC-41BBC19C7BD3Q37880925-486163A4-DEA6-453F-A86E-D6592EC95303Q38963109-B819BC33-64D4-458D-B286-F36DBE7C6478Q39051350-6F395405-98B9-468C-81DD-68FFB6AB6CB2Q41181423-9CFB6B11-5C68-4629-B624-CF17584D6F7AQ42978617-E48D815A-7A77-4F02-B510-BBC8AD9FF02AQ49368735-B72C6C5C-C108-4EB7-8F78-ACCB2C091058Q50953524-4474C3C8-2EF4-44D4-A6AF-2AA7A0F41FA2Q53275045-C2A94853-814E-4CDA-8881-A9D7675D44B4Q53764006-8110E63A-AF30-4436-8688-6D7F925B13B8Q54509603-F8843DC7-D320-450F-A335-85C0CDE996E9Q55431488-8AA1D1DA-484A-4786-8924-68A6C2DC3600
P2860
Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Pharmacokinetic characterizati ...... rom ginseng, in rats and dogs.
@en
Pharmacokinetic characterizati ...... rom ginseng, in rats and dogs.
@nl
type
label
Pharmacokinetic characterizati ...... rom ginseng, in rats and dogs.
@en
Pharmacokinetic characterizati ...... rom ginseng, in rats and dogs.
@nl
prefLabel
Pharmacokinetic characterizati ...... rom ginseng, in rats and dogs.
@en
Pharmacokinetic characterizati ...... rom ginseng, in rats and dogs.
@nl
P2093
P1476
Pharmacokinetic characterizati ...... rom ginseng, in rats and dogs.
@en
P2093
Guang-Ji Wang
Jian-Guo Sun
Mei-Juan Xu
Yuan-Ting Zheng
Yuan-Wei Jia
P304
P356
10.1016/J.FCT.2009.06.013
P577
2009-06-11T00:00:00Z